HomeInsightsBoard of Directors

Zydus Lifesciences Ltd Board of Directors

Zydus Lifesciences Ltd Board of Directors

stocks purchased

₹ 1.4 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

15.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Board of Directors at Zydus Lifesciences Ltd

Name
Designation
Akhil MonappaIndependent Director
Apurva DiwanjiIndependent Director
Bhadresh ShahIndependent Director
Dhaval SoniCompany Sec. & Compli. Officer
Ganesh NayakWhole-time Director

Key Highlights

  • Pankaj R Patel continues to serve as the Chairman (Non-Executive) in 2024, maintaining the same position as in the previous year.
  • Sharvil P Patel continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
  • Mukesh M Patel joins the board as Non Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Apurva S Diwanji joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Ganesh N Nayak joins the board as Whole-time Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

Share Price

-

stock direction

Last updated on:

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 2024944.25
19 Nov 2024946.9
18 Nov 2024944.95
14 Nov 2024958.05
13 Nov 2024963.6
12 Nov 2024950.1
11 Nov 2024968.55
08 Nov 2024968.65
07 Nov 2024972.6
06 Nov 2024995

Company Fundamentals for Zydus Lifesciences Ltd

Market Cap

95,013 Cr

EPS

42.5

P/E Ratio (TTM) *

22.2

P/B Ratio (TTM) *

4.3

Day’s High *

951.8

Day’s Low

939.6

DTE *

0.0

ROE *

19.7

52 Week High

1323.9

52 Week Low

628.05

ROCE *

25.0

Market Price of Zydus Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Zydus Lifesciences Ltd News Hub

News

Zydus Life Q2 PAT rises 14% YoY to Rs 911 cr

Revenue from operations grew 19.87% year on year (YoY) to Rs 5,237 crore in the quarter en...

Read more

12 Nov 202415:22

News

Zydus Lifesciences to table results

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Nove...

Read more

31 Oct 202411:58

News

Zydus Life rises on in-principle approval from WHO for typhoid vaccine

ZyVac TCV is now eligible for purchase by United Nations (UN) agencies. It is indigenously...

Read more

23 Oct 202414:50

News

Zydus receives USFDA approval for Fludrocortisone Acetate Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

18 Oct 202409:29

News

Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab

Fludrocortisone Acetate tablets are indicated as partial replacement therapy for primary a...

Read more

18 Oct 202412:47

News

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of...

Read more

15 Oct 202410:08

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Sep 2021

Transcript

Jan 2021

PPT

Aug 2020

PPT

Feb 2020

PPT

FAQs for Board of Directors of Zydus Lifesciences Ltd

How are members of Zydus Lifesciences Ltd Board of Directors selected?

Members of the Zydus Lifesciences Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Zydus Lifesciences Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Zydus Lifesciences Ltd Board of Directors?

Shareholders can interact with the Zydus Lifesciences Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Zydus Lifesciences Ltd Board of Directors meet?

The Zydus Lifesciences Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Zydus Lifesciences Ltd Board of Directors?

The Zydus Lifesciences Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Zydus Lifesciences Ltd?

The current Board of Directors at Zydus Lifesciences Ltd includes Pankaj R Patel( Chairman (Non-Executive)) ,Sharvil P Patel( Managing Director) ,Mukesh M Patel( Non Executive Director) ,Apurva S Diwanji( Independent Director) ,Ganesh N Nayak( Whole-time Director) . The full list can be found on Zydus Lifesciences Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*